WG Critical Care Released New Calcium Gluconate Injection

The company launched a new pharmacy bulk package with significantly lower aluminum content for clinical use.

Updated on Sept. 29, 2026 in Nursing Jobs

Isometric editorial illustration of a glass reagent bottle on a white platform, representing clinical medical supply developments.
WG Critical Care has launched a new 10,000 mg/100 mL Calcium Gluconate Injection, designed to lower aluminum exposure in critical care patient treatments. AI Illustration. Upload story photo >

Live Poll

Do you trust pharmaceutical companies to proactively improve safety standards in essential medications?

WG Critical Care has introduced a 10,000 mg/100 mL Calcium Gluconate Injection pharmacy bulk package. The product aims to assist healthcare organizations in reducing patient exposure to aluminum.

Why it matters

Reducing aluminum levels in intravenous treatments is a priority for clinical safety, as trace metal accumulation can pose risks to patients. This new product provides hospitals with a specialized option to minimize such exposure during regular care.

The new pharmacy bulk package features a 10,000 mg concentration of Calcium Gluconate per 100 mL unit. This formulation achieves a 16-20x reduction in aluminum content compared to leading industry alternatives.

The players

WG Critical Care

A pharmaceutical company headquartered in Paramus, New Jersey, that specializes in critical care and injectable medical products.

The details

The product is now available through authorized distributors, wholesalers, and group purchasing channels across the United States. It was developed to help facilities address concerns regarding trace aluminum levels in parenteral nutrition and critical care therapies.

Timeline

  1. WG Critical Care announced the product release on September 29, 2026.

Market Landscape

The release follows the FDA's ongoing guidance on aluminum in large and small volume parenterals, reflecting a broader industry shift toward high-purity medical manufacturing. This positions WG Critical Care to compete more effectively in hospitals prioritizing long-term patient safety.

Clinicians and hospital pharmacists can now procure this lower-aluminum option for their standard patient care protocols. This change helps health systems improve safety standards without requiring adjustments to existing injection administration workflows.

The takeaway

Healthcare providers should review their current supply inventory to determine if this new formulation meets their specific needs for minimizing patient aluminum exposure. Proactively updating clinical supplies can enhance patient safety standards across critical care departments.

Further reading

For more information on current healthcare staffing and clinical supply standards, visit the United States Nursing Jobs section.

Live Poll

Do you trust pharmaceutical companies to proactively improve safety standards in essential medications?